These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 27810704

  • 1. Selective corticotropin-releasing factor 1 receptor antagonist E2508 reduces restraint stress-induced defecation and visceral pain in rat models.
    Taguchi R, Shikata K, Furuya Y, Hirakawa T, Ino M, Shin K, Shibata H.
    Psychoneuroendocrinology; 2017 Jan; 75():110-115. PubMed ID: 27810704
    [Abstract] [Full Text] [Related]

  • 2. Selective corticotropin-releasing factor 1 receptor antagonist E2508 has potent antidepressant-like and anxiolytic-like properties in rodent models.
    Taguchi R, Shikata K, Furuya Y, Ino M, Shin K, Shibata H.
    Behav Brain Res; 2016 Oct 01; 312():138-47. PubMed ID: 27297028
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological evaluation of a novel corticotropin-releasing factor 1 receptor antagonist T-3047928 in stress-induced animal models in a comparison with alosetron.
    Itomi Y, Tanaka T, Matsushita K, Kawamura T, Kojima T, Aso K, Matsumoto-Okano S, Tsukimi Y.
    Neurogastroenterol Motil; 2020 May 01; 32(5):e13795. PubMed ID: 31970891
    [Abstract] [Full Text] [Related]

  • 4. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    Funatsu T, Takeuchi A, Hirata T, Keto Y, Akuzawa S, Sasamata M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):190-5. PubMed ID: 17658508
    [Abstract] [Full Text] [Related]

  • 5. EFFECT OF 5-HT3 ANTAGONIST ONDANSETRON ON WRAP-RESTRAINT AND CONDITIONED EMOTIONAL STRESS INDUCED DEFECATION.
    Karan RS, Saha L, Handu SS, Bhargava VK.
    Indian J Physiol Pharmacol; 1999 Jan 14; 43(1):129-32. PubMed ID: 27093752
    [Abstract] [Full Text] [Related]

  • 6. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T.
    Eur J Pharmacol; 2020 Nov 15; 887():173565. PubMed ID: 32946869
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
    Hirata T, Keto Y, Funatsu T, Akuzawa S, Sasamata M.
    J Pharmacol Sci; 2007 Jul 15; 104(3):263-73. PubMed ID: 17652911
    [Abstract] [Full Text] [Related]

  • 8. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
    Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T.
    J Endocrinol; 2018 Nov 01; 239(2):241-252. PubMed ID: 30139928
    [Abstract] [Full Text] [Related]

  • 9. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.
    Buckley MM, O'Halloran KD, Rae MG, Dinan TG, O'Malley D.
    J Physiol; 2014 Dec 01; 592(23):5235-50. PubMed ID: 25260633
    [Abstract] [Full Text] [Related]

  • 10. Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
    Hirata T, Keto Y, Nakata M, Takeuchi A, Funatsu T, Akuzawa S, Sasamata M, Miyata K.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):281-4. PubMed ID: 18456254
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effect of 5-hydroxytryptamine 3 and neurokinin 1 receptor antagonism in rodent models of somatic and visceral pain.
    Greenwood-Van Meerveld B, Mohammadi E, Tyler K, Pietra C, Bee LA, Dickenson A.
    J Pharmacol Exp Ther; 2014 Oct 10; 351(1):146-52. PubMed ID: 25077526
    [Abstract] [Full Text] [Related]

  • 12. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
    Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T.
    Eur J Pharmacol; 2019 Jun 05; 852():198-206. PubMed ID: 30935894
    [Abstract] [Full Text] [Related]

  • 13. 5-HT3 receptor signaling in serotonin transporter-knockout rats: a female sex-specific animal model of visceral hypersensitivity.
    El-Ayache N, Galligan JJ.
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan 01; 316(1):G132-G143. PubMed ID: 30359082
    [Abstract] [Full Text] [Related]

  • 14. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?
    Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, Tong G, Dockens R, Zinsmeister AR.
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun 01; 296(6):G1299-306. PubMed ID: 19342506
    [Abstract] [Full Text] [Related]

  • 15. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.
    Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T.
    J Gastroenterol; 2017 Jan 01; 52(1):72-80. PubMed ID: 27075754
    [Abstract] [Full Text] [Related]

  • 16. 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.
    Kishibayashi N, Miwa Y, Hayashi H, Ishii A, Ichikawa S, Nonaka H, Yokoyama T, Suzuki F.
    J Med Chem; 1993 Oct 29; 36(22):3286-92. PubMed ID: 8230119
    [Abstract] [Full Text] [Related]

  • 17. Melatonin attenuates stress-induced defecation: lesson from a rat model of stress-induced gut dysfunction.
    Song GH, Gwee KA, Moochhala SM, Ho KY.
    Neurogastroenterol Motil; 2005 Oct 29; 17(5):744-50. PubMed ID: 16185314
    [Abstract] [Full Text] [Related]

  • 18. The newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats.
    Million M, Zhao JF, Luckey A, Czimmer J, Maynard GD, Kehne J, Hoffman DC, Taché Y.
    PLoS One; 2013 Oct 29; 8(9):e73749. PubMed ID: 24040053
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of ramosetron, a novel therapeutic agent for IBS.
    Hirata T, Funatsu T, Keto Y, Nakata M, Sasamata M.
    Inflammopharmacology; 2007 Feb 29; 15(1):5-9. PubMed ID: 17323187
    [Abstract] [Full Text] [Related]

  • 20. Water avoidance stress induces visceral hyposensitivity through peripheral corticotropin releasing factor receptor type 2 and central dopamine D2 receptor in rats.
    Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T.
    Neurogastroenterol Motil; 2016 Apr 29; 28(4):522-31. PubMed ID: 26662216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.